GLUE vs RTX · rev $13.2M vs P/E 36, rev $46.78B
Monte Rosa Therapeutics Inc (GLUE) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
GLUE currently screens at market cap $1.56B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the GLUE and RTX stock pages for the full models.
Not investment advice.